N-Nitrosamine Generation From Ingested Nitrate Via Nitric Oxide in Subjects With and Without Gastroesophageal Reflux

Gastroenterology

Volumn 133, Issue 1, 2007, Pages 164-174

  Winter, Jack W ^a   Paterson, Stuart ^a   Scobie, Gordon ^a   Wirz, Angela ^a   Preston, Tom ^b   McColl, Kenneth E L ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b SCOTTISH UNIVERSITIES ENVIRONMENTAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHOLINE; NITRATE; NITRIC OXIDE; NITRITE; NITROGEN 15; NITROSAMINE; NITROSOMORPHOLINE; PHOSPHATE; PROTON;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; LIPID MEMBRANE; MALE; NITROSATIVE STRESS; PRIORITY JOURNAL; SILASTIC TUBE; STOMACH ACID; UPPER GASTROINTESTINAL TRACT;

EID: 34447107670     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.04.047     Document Type: Article

References (59)

1. Blot W.J., Devesa S.S., Kneller R.W., and Fraumeni Jr. J.F. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265 (1991) 1287-1289
2. Blot W.J., and McLaughlin J.K. The changing epidemiology of esophageal cancer. Semin Oncol 26 (1999) 2-8
3. Botterweck A.A., Schouten L.J., Volovics A., Dorant E., and van Den Brandt P.A. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 29 (2000) 645-654
4. Pohl H., and Welch H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97 (2005) 142-146
5. Powell J., and McConkey C.C. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 62 (1990) 440-443
6. El-Serag H.B., Mason A.C., Petersen N., and Key C.R. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 50 (2002) 368-372
7. Lagergren J., Bergstrom R., Lindgren A., and Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340 (1999) 825-831
8. Wu A.H., Tseng C.C., and Bernstein L. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer 98 (2003) 940-948
9. Engel L.S., Chow W.H., Vaughan T.L., Gammon M.D., Risch H.A., Stanford J.L., Schoenberg J.B., Mayne S.T., Dubrow R., Rotterdam H., West A.B., Blaser M., Blot W.J., Gail M.H., and Fraumeni Jr. J.F. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95 (2003) 1404-1413
10. Spechler S.J., and Goyal R.K. Barrett's esophagus. N Engl J Med 315 (1986) 362-371
11. Winters Jr. C., Spurling T.J., Chobanian S.J., Curtis D.J., Esposito R.L., Hacker III J.F., Johnson D.A., Cruess D.F., Cotelingam J.D., Gurney M.S., et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 92 (1987) 118-124
12. Sarr M.G., Hamilton S.R., Marrone G.C., and Cameron J.L. Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. Am J Surg 149 (1985) 187-193
13. Sampliner R.E., and The Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 93 (1998) 1028-1032
14. Helicobacter and Cancer Collaborative G. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49 (2001) 347-353
15. Sugiyama A., Maruta F., Ikeno T., Ishida K., Kawasaki S., Katsuyama T., Shimizu N., and Tatematsu M. Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res 58 (1998) 2067-2069
16. Leach S.A. Mechanisms of endogenous N-nitrosation. In: Hill M.J. (Ed). Nitrosamines: toxicology and microbiology (1988), Ellis Horwood, Chichester 69-87
17. Mirvish S.S. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 93 (1995) 17-48
18. Gangolli S.D., van den Brandt P.A., Feron V.J., Janzowsky C., Koeman J.H., Speijers G.J., Spiegelhalder B., Walker R., and Wisnok J.S. Nitrate, nitrite and N-nitroso compounds. Eur J Pharmacol 292 (1994) 1-38
19. Bartholomew B., and Hill M.J. The pharmacology of dietary nitrate and the origin of urinary nitrate. Food Chem Toxicol 22 (1984) 789-795
20. Walker R. Nitrates, nitrites and N-nitrosocompounds: a review of the occurrence in food and diet and the toxicological implications. Food Addit Contam 7 (1990) 717-768
21. Granli T., Dahl R., Brodin P., and Bockman O.C. Nitrate and nitrite concentrations in human saliva: variations with salivary flow-rate. Food Chem Toxicol 27 (1989) 675-680
22. van Maanen J.M., van Geel A.A., and Kleinjans J.C. Modulation of nitrate-nitrite conversion in the oral cavity. Cancer Detect Prev 20 (1996) 590-596
23. Ruddell W.S., Blendis L.M., and Walters C.L. Nitrite and thiocyanate in the fasting and secreting stomach and in saliva. Gut 18 (1977) 73-77
24. McKnight G.M., Smith L.M., Drummond R.S., Duncan C.W., Golden M., and Benjamin N. Chemical synthesis of nitric oxide in the stomach from dietary nitrate in humans. Gut 40 (1997) 211-214
25. Mowat C., Carswell A., Wirz A., and McColl K.E. Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice. Gastroenterology 116 (1999) 813-822
26. Forman D., Al-Dabbagh S., and Doll R. Nitrates, nitrites and gastric cancer in Great Britain. Nature 313 (1985) 620-625
27. Boulos P.B., Whitfield P.F., Dave M., Faber R.G., and Hobsley M. Thiocyanate as a marker of saliva in gastric juice?. Gut 21 (1980) 18-22
28. Boyland E., and Walker S.A. Effect of thiocyanate on nitrosation of amines. Nature 248 (1974) 601-602
29. Schorah C.J., Sobala G.M., Sanderson M., Collis N., and Primrose J.N. Gastric juice ascorbic acid: effects of disease and implications for gastric carcinogenesis. Am J Clin Nutr 53 (1991) 287S-293S
30. Archer M.C., Tannenbaum S.R., Fan T.Y., and Weisman M. Reaction of nitrite with ascorbate and its relation to nitrosamine formation. J Natl Cancer Inst 54 (1975) 1203-1205
31. Suzuki H., Iijima K., Moriya A., McElroy K., Scobie G., Fyfe V., and McColl K.E. Conditions for acid catalysed luminal nitrosation are maximal at the gastric cardia. Gut 52 (2003) 1095-1101
32. Iijima K., Henry E., Moriya A., Wirz A., Kelman A.W., and McColl K.E. Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction. Gastroenterology 122 (2002) 1248-1257
33. Liu X., Miller M.J., Joshi M.S., Thomas D.D., and Lancaster Jr. J.R. Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc Natl Acad Sci U S A 95 (1998) 2175-2179
34. Wink D.A., Fellisch M., Vadovotz Y., et al. The chemical biology of nitric oxide. In: DL Gilbert C.C. (Ed). Reactive oxygen species in biological systems (1999), Kluwer Academic/Plenum Publishers, New York
35. Iijima K., Grant J., McElroy K., Fyfe V., Preston T., and McColl K.E. Novel mechanism of nitrosative stress from dietary nitrate with relevance to gastro-oesophageal junction cancers. Carcinogenesis 24 (2003) 1951-1960
36. Lewis R.S., Deen W.M., Tannenbaum S.R., and Wishnok J.S. Membrane mass spectrometer inlet for quantitation of nitric oxide. Biol Mass Spectrom 22 (1993) 45-52
37. Tamir S., Lewis R.S., de Rojas Walker T., Deen W.M., Wishnok J.S., and Tannenbaum S.R. The influence of delivery rate on the chemistry and biological effects of nitric oxide. Chem Res Toxicol 6 (1993) 895-899
38. Walter A., and Gutknecht J. Permeability of small nonelectrolytes through lipid bilayer membranes. J Membr Biol 90 (1986) 207-217
39. Suzuki H., Iijima K., Scobie G., Fyfe V., and McColl K.E. Nitrate and nitrosative chemistry within Barrett's oesophagus during acid reflux. Gut 54 (2005) 1527-1535
40. Fletcher J., Wirz A., Young J., Vallance R., and McColl K.E. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology 121 (2001) 775-783
41. Collins P., Rogers S., Jackson J., and McCartan B. Psoriasis, psoriatic arthritis and the possible association with Sjogren's syndrome. Br J Dermatol 126 (1992) 242-245
42. Diem K., and Lentner C. Documenta Geigy scientific tables (1975), Geigy Pharmaceutical Company, Manchester
43. Hill M.J. Bacterial N-nitrosation and gastric carcinogenesis in humans. Ital J Gastroenterol 23 (1991) 17-23
44. Correa P., Haenszel W., Cuello C., Tannenbaum S., and Archer M. A model for gastric cancer epidemiology. Lancet 2 (1975) 58-60
45. Shuker D.E., and Margison G.P. Nitrosated glycine derivatives as a potential source of O6-methylguanine in DNA. Cancer Res 57 (1997) 366-369
46. Shuker D.E.G., Tannenbaum S.R., and Wishnok J.S. N-nitroso bile-acid conjugates. 1. Synthesis, chemical-reactivity, and mutagenic activity. J Organ Chem 46 (1981) 2092-2096
47. Sedgwick B. Nitrosated peptides and polyamines as endogenous mutagens in O-6-alkylguanine-DNA alkyltransferase deficient cells. Carcinogenesis 18 (1997) 1561-1567
48. Shephard S.E., Wakabayashi K., and Nagao M. Mutagenic activity of peptides and the artificial sweetener aspartame after nitrosation. Food Chem Toxicol 31 (1993) 323-329
49. Takeda Y., and Kanaya H. N-nitrosospermidine: the principal nitrosation product of spermidine. Experientia 37 (1981) 1007-1008
50. Batzri S., Harmon J.W., Schweitzer E.J., and Toles R. Bile-acid accumulation in gastric-mucosal cells. Proc Soc Exp Biol Med 197 (1991) 393-399
51. Ruiz F., Corrales F.J., Miqueo C., and Mato J.M. Nitric oxide inactivates rat hepatic methionine adenosyltransferase in vivo by S-nitrosylation. Hepatology 28 (1998) 1051-1057
52. Laval F., Wink D.A., and Laval J. A discussion of mechanisms of NO genotoxicity: implication of inhibition of DNA repair proteins. Rev Physiol Biochem Pharmacol 131 (1997) 175-191
53. Chueh L.L., Nakamura T., Nakatsu Y., Sakumi K., Hayakawa H., and Sekiguchi M. Specific amino-acid-sequences required for 06-methylguanine-DNA methyltransferase activity-analyses of 3 residues at or near the methyl acceptor site. Carcinogenesis 13 (1992) 837-843
54. Schmiedeskamp M., and Klevit R.E. Zinc-finger diversity. Curr Opin Struct Biol 4 (1994) 28-35
55. Lindahl T., and Barnes D.E. Mammalian DNA ligases. Ann Rev Biochem 61 (1992) 251-281
56. O' Connor T.R., Graves R.J., Demurcia G., Castaing B., and Laval J. Fpg protein of Escherichia-coli is a zinc finger protein whose cysteine residues have a structural and or functional-role. J Biol Chem 268 (1993) 9063-9070
57. Fitzgerald R.C., Omary M.B., and Triadafilopoulos G. Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model. J Clin Invest 98 (1996) 2120-2128
58. Kaur B.S., and Triadafilopoulos G. Acid- and bile-induced PGE(2) release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-epsilon dependent. Am J Physiol 283 (2002) G327-G334
59. Souza R.F., Shewmake K., Terada L.S., and Spechler S.J. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 122 (2002) 299-307